Our study provided evidence that endostar decreased MMP-2, MMP-9, and MMP-14 expression, which could be responsible for reduced angiogenesis in treated CNE-2 NPC xenografts compared to controls (Fig. 6). Here, MMP2 is linked to nasopharyngeal carcinoma.